| [1] |
Gu Y, Xu H, Tang D. Mechanisms of primary membranous nephropathy[J]. Biomolecules, 2021, 11(4):513.
DOI
URL
|
| [2] |
Beck L H Jr, Bonegio R G, Lambeau G, et al. M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy[J]. N Engl J Med, 2009, 361(1):11-21.
DOI
URL
|
| [3] |
Glassock R J. The pathogenesis of membranous nephropathy:evolution and revolution[J]. Curr Opin Nephrol Hypertens, 2012, 21(3):235-242.
DOI
URL
|
| [4] |
Garcia-vives E, Solé C, Moliné T, et al. Antibodies to M-type phospholipase A2 receptor (PLA2R) in membranous lupus nephritis[J]. Lupus, 2019, 28(3):396-405.
DOI
PMID
|
| [5] |
Kidney Disease:Improving Global Outcomes (KDIGO) Glomerular Diseases Work Group. KDIGO 2021 clinical practice guideline for the management of glomerular diseases[J]. Kidney Int, 2021, 100(4S):S1-S276.
DOI
PMID
|
| [6] |
方玲, 顾向明, 周泽红, 等. 两种方法检测血清抗磷脂酶A2受体抗体在膜性肾病中的应用分析[J]. 检验医学与临床, 2017, 14(15):2196-2198.
|
| [7] |
孙淼鑫, 王鼎鼎, 吴浩文, 等. 磷脂酶A2受体相关性膜性肾病发病机制及临床应用进展[J]. 临床肾脏病杂志, 2025, 25(9):807-810.
|
| [8] |
游延军, 张欢, 向乾银, 等. 原发性膜性肾病标志物抗PLA2R抗体检测方法比较[J]. 检验医学, 2023, 38(12):1153-1156.
DOI
|
| [9] |
符克英, 蔡俊宏, 符生苗, 等. IIF与ELISA在抗磷脂酶A2受体抗体检测中相关性[J]. 中国热带医学, 2015, 15(4):457-459.
|
| [10] |
Tomas N M, Beck L H Jr, Meyer-schwesinger C, et al. Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy[J]. N Engl J Med, 2014, 371(24):2277-2287.
DOI
URL
|
| [11] |
Sethi S, Debiec H, Madden B, et al. Neural epidermal growth factor-like 1 protein (NELL-1) associated membranous nephropathy[J]. Kidney Int, 2020, 97(1):163-174.
DOI
URL
|
| [12] |
Sethi S, Debiec H, Madden B, et al. Semaphorin 3B-associated membranous nephropathy is a distinct type of disease predominantly present in pediatric patients[J]. Kidney Int, 2020, 98(5):1253-1264.
DOI
PMID
|
| [13] |
程文荣, 程虹, 王国勤, 等. PLA2R相关膜性肾病血清抗PLA2R抗体检测的诊断界值及其影响因素探讨[J]. 中国实用内科杂志, 2022, 42(9):761-765.
|
| [14] |
Li C, Li P, Guo W, et al. The optimal anti-phospholipase A2 receptor cutoff for the diagnosis of idiopathic membranous nephropathy:a single-center retrospective study[J]. Korean J Intern Med, 2022, 37(1):154-166.
DOI
URL
|
| [15] |
蒋真斌, 蔡美顺, 董葆, 等. 适合中国人的抗磷脂酶A2受体抗体临界值的界定[J]. 中华肾脏病杂志, 2020, 36(5):379-384.
DOI
|
| [16] |
Tampoia M, Migliucci F, Villani C, et al. Definition of a new cut-off for the anti-phospholipase A 2 receptor (PLA2R) autoantibody immunoassay in patients affected by idiopathic membranous nephropathy[J]. J Nephrol, 2018, 31(6):899-905.
DOI
URL
|